Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2023-02-17 | Future report Set alerts | |
Q2 2022 | 2022-07-28 | 0.00 | 0.00 |
Q1 2022 | 2022-05-10 | 0.49 | 0.49 |
Q4 2021 | 2022-02-17 | 1.15 | 1.15 |
Q3 2021 | 2021-11-03 | 1.11 | 1.11 |
Q2 2021 | 2021-07-29 | 3.70 | 3.70 |
Q1 2021 | 2021-05-05 | 2.37 | 2.37 |
Q4 2020 | 2021-02-16 | -1.72 | -1.72 |
Q3 2020 | 2020-11-04 | -1.73 | -1.73 |
Q2 2020 | 2020-08-03 | -0.86 | -0.86 |
2016-07-06 | Lower Price Target | Wunderlich | Hold | $53.00 to $49.00 |
2016-06-30 | Initiated Coverage | Evercore ISI | Buy | $40.00 |
2016-06-24 | Lower Price Target | Pivotal Research | Buy | $50.00 to $41.00 |
2016-06-23 | Reiterated Rating | Jefferies Group | Buy | $53.00 to $46.00 |
2016-06-22 | Lower Price Target | Wunderlich | Buy | $60.00 to $53.00 |
2016-05-13 | Lower Price Target | Citigroup Inc. | Buy | $54.00 to $50.00 |
2016-04-18 | Boost Price Target | Pivotal Research | Buy | $48.00 to $50.00 |
2016-03-16 | Lower Price Target | Citigroup Inc. | Buy | $59.00 to $54.00 |
2016-02-17 | Reiterated Rating | RBC Capital | Outperform | $52.00 to $55.00 |
2016-02-17 | Reiterated Rating | Royal Bank Of Canada | Outperform | $52.00 to $55.00 |
2016-01-25 | Lower Price Target | Wunderlich | Buy | $65.00 to $60.00 |
2016-01-19 | Lower Price Target | Barclays | Overweight | $53.00 to $45.00 |
2016-01-19 | Lower Price Target | Barclays PLC | Overweight | $53.00 to $45.00 |
2016-01-15 | Lower Price Target | Pivotal Research | Buy | $61.00 to $48.00 |
2016-01-14 | Lower Price Target | RBC Capital | Outperform | $58.00 to $52.00 |
2016-01-11 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $56.00 to $43.00 |
2016-01-07 | Lower Price Target | Macquarie | Outperform | $57.00 to $55.00 |
2015-12-04 | Reiterated Rating | Jefferies Group | Buy | $59.00 to $54.00 |
2015-11-09 | Reiterated Rating | Macquarie | Buy | $60.00 to $57.00 |
2015-11-09 | Lower Price Target | RBC Capital | Outperform | $59.00 to $58.00 |
2015-11-02 | Initiated Coverage | BNP Paribas | Outperform | $60.00 |
2015-10-23 | Reiterated Rating | Jefferies Group | Buy | $69.00 to $59.00 |
2015-10-19 | Lower Price Target | Credit Suisse | $56.70 to $50.00 | |
2015-10-19 | Lower Price Target | Credit Suisse Group AG | $56.70 to $50.00 | |
2015-10-17 | Reiterated Rating | RBC Capital | Buy | |
2015-10-16 | Lower Price Target | RBC Capital | Outperform | $60.00 to $59.00 |
2015-10-15 | Lower Price Target | Barclays | $57.00 to $55.00 | |
2015-10-02 | Reiterated Rating | Goldman Sachs | Conviction-Buy to Buy | $70.00 to $60.00 |
2015-10-02 | Reiterated Rating | Goldman Sachs Group Inc. | Conviction-Buy to Buy | $70.00 to $60.00 |
2015-08-20 | Boost Price Target | Pivotal Research | Buy | $61.00 to $69.00 |
2015-08-06 | Boost Price Target | RBC Capital | Outperform | $58.00 to $60.00 |
2015-07-16 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $55.00 |
2015-07-15 | Upgrade | Goldman Sachs | Buy to Conviction-Buy | |
2015-07-14 | Lower Price Target | Pivotal Research | Buy | $64.00 to $61.00 |
2015-07-02 | Reiterated Rating | Barclays | Overweight | $55.00 to $58.00 |
2015-06-12 | Reiterated Rating | Credit Suisse | Outperform | $55.00 to $60.00 |
2015-06-01 | Reiterated Rating | Jefferies Group | Buy | $70.00 |
2015-05-23 | Reiterated Rating | Jefferies Group | Buy | $59.00 |
2015-05-21 | Boost Price Target | Nomura | Buy | $56.00 to $66.00 |
2015-05-21 | Boost Price Target | Nomura Holdings Inc. | Buy | $56.00 to $66.00 |
2015-03-20 | Boost Price Target | Jefferies Group | Buy | $58.00 to $59.00 |
2015-02-20 | Boost Price Target | Pivotal Research | Buy | $55.00 to $64.00 |
2015-02-18 | Boost Price Target | Wunderlich | Buy | $61.00 to $65.00 |
2015-02-11 | Initiated Coverage | BNP Paribas | Outperform | |
2015-01-15 | Initiated Coverage | Morgan Stanley | Overweight | $56.00 |
2014-12-17 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $55.00 |
2014-09-17 | Boost Price Target | Wunderlich | Buy | $55.00 to $61.00 |
2014-09-09 | Initiated Coverage | RBC Capital | Outperform | |
2014-09-08 | Lower Price Target | Pivotal Research | $60.00 to $58.00 | |
2014-08-18 | Boost Price Target | Credit Suisse | $46.00 to $50.00 | |
2014-08-08 | Boost Price Target | Jefferies Group | $51.00 to $55.00 | |
2014-07-14 | Boost Price Target | Pivotal Research | $53.00 to $60.00 | |
2014-05-30 | Boost Price Target | Evercore ISI | Overweight | $56.00 |
2014-05-29 | Downgrade | Bank of America | Buy to Neutral | |
2014-05-28 | Boost Price Target | Goldman Sachs | $56.00 to $65.00 | |
2014-05-22 | Boost Price Target | Pivotal Research | $51.00 to $53.00 | |
2014-05-07 | Reiterated Rating | Nomura | Buy | $60.00 |
2014-04-30 | Reiterated Rating | Wunderlich | Buy | |
2014-04-11 | Reiterated Rating | Goldman Sachs | Buy | |
2014-04-10 | Upgrade | Goldman Sachs | Buy to Conviction-Buy | $53.00 |
2014-03-25 | Reiterated Rating | Wunderlich | Buy | $48.00 to $55.00 |
2014-03-24 | Lower Price Target | Jefferies Group | $98.00 to $51.00 | |
2014-03-05 | Lower Price Target | Pivotal Research | $103.00 to $51.00 | |
2014-01-28 | Lower Price Target | Jefferies Group | $102.00 to $98.00 | |
2013-12-19 | Initiated Coverage | Buckingham Research | Buy | $100.00 |
2013-12-18 | Boost Price Target | Jefferies Group | Buy | $92.00 to $102.00 |
2013-12-03 | Boost Price Target | Pivotal Research | $103.00 | |
2013-11-11 | Boost Price Target | Evercore ISI | Overweight | $90.00 |
2013-10-18 | Lower Price Target | Pivotal Research | Buy | $103.00 to $101.00 |
2013-10-16 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $90.00 to $97.00 |
2013-10-16 | Downgrade | Goldman Sachs | Conviction-Buy to Buy | $105.00 to $100.00 |
2013-10-15 | Lower Price Target | Wunderlich | Buy | $102.00 to $96.00 |
2013-10-01 | Initiated Coverage | Jefferies Group | Buy | $92.00 |
2013-09-20 | Initiated Coverage | BNP Paribas | Outperform | $98.00 |
2013-03-26 | Reiterated | Wunderlich | Buy | $75 to $84 |
2012-09-24 | Reiterated | HSBC Securities | Overweight | $60 to $66 |
2011-03-01 | Reiterated | Wunderlich | Buy | $43 to $47 |
2010-06-23 | Reiterated | Hudson Square Research | Buy | $32 to $30 |
2009-11-30 | Initiated | JP Morgan | Neutral | |
2009-09-04 | Initiated | Credit Suisse | Outperform | $26 |
2009-08-04 | Reiterated | Morgan Joseph | Buy | $20 to $25 |
2016-07-06 | Lower Price Target | Wunderlich | Hold | $53.00 to $49.00 |
2016-06-30 | Initiated Coverage | Evercore ISI | Buy | $40.00 |
2016-06-24 | Lower Price Target | Pivotal Research | Buy | $50.00 to $41.00 |
2016-06-23 | Reiterated Rating | Jefferies Group | Buy | $53.00 to $46.00 |
2016-06-22 | Lower Price Target | Wunderlich | Buy | $60.00 to $53.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In LBTYA 214 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
HARRIS ASSOCIATES L P | 34.20M |
Artisan Partners Limited Partnership | 12.63M |
Luxor Capital Group, LP | 11.16M |
BAUPOST GROUP LLC/MA | 7.19M |
BlackRock Inc. | 6.33M |
ALTRINSIC GLOBAL ADVISORS LLC | 6.31M |
DODGE & COX | 4.88M |
BlackRock Institutional Trust Company, N.A. | 4.69M |
RENAISSANCE TECHNOLOGIES LLC | 3.40M |
Kiltearn Partners LLP | 2.64M |
STATE STREET CORP | 2.57M |
BANK OF AMERICA CORP /DE/ | 2.42M |
CITADEL ADVISORS LLC | 2.38M |
Vanguard Group, Inc | 2.36M |
Grantham, Mayo, Van Otterloo & Co. LLC | 2.20M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
MALONE JOHN C | 3.14% (6757225) | ASCMA / CHTR / GNCMA / LBRDK / LBTYA / LGF / LINTA / LMCA / LVNTA / SIRI / STRZA / |
FRIES MICHAEL T President & CEO | 0.56% (1210552) | LBTYA / |
GOULD PAUL A | 0.45% (968264) | AP / LBTYA / |
Karsten Diederik EVP, European BB Ops | 0.08% (174059) | LBTYA / |
WARGO J DAVID | 0.05% (110558) | LBRDK / LBTYA / STRA / |
DICK JOHN W | 0.04% (79455) | LBTYA / |
Nair Balan EVP & CTO | 0.03% (61903) | ADTN / CHTR / LBTYA / |
ROMRELL LARRY E | 0.03% (59295) | LBTYA / LINTA / LMCA / LVNTA / STRZA / |
COLE ANDREW | 0.02% (50002) | LBTYA / |
HALL BRYAN H EVP, Gen Counsel & Secretary | 0.02% (43237) | LBTYA / |
Green Richard R | 0.01% (15767) | GNCMA / LBRDK / LBTYA / |
BRACKEN CHARLES H R EVP & Co-CFO | 0.01% (15351) | LBTYA / |